> For the complete documentation index, see [llms.txt](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/vitamin-k2-research-notes.md).
# Vitamin K2 research notes
Vitamin K2 research includes dosing context and caution points. Use these sources for reference, not as a treatment protocol.
***
### MK‑4 and fracture risk
**Vitamin *****K2 in the MK‑4 form***** helps “activate” a bone protein called osteocalcin.**\
\
When osteocalcin is well activated, it can lock calcium into the bone structure more effectively, which is one reason researchers think it may help reduce fracture risk.
Several studies have tested different daily doses of MK‑4 in women with fragile bones:
* In one study, a **low dose (5 mg per day)** worked just as well as a **very high dose (45 mg per day)** for activating osteocalcin in women who had already had hip or spinal compression fractures.
* In another study, an even **lower dose (1.5 mg per day)** also improved this osteocalcin activation in postmenopausal Japanese women.
* Several Japanese studies studied higher **45 mg/day doses** in osteoporosis and showed improvements.
Why does this matter?
* People with **more “inactive” osteocalcin** in their blood (under‑carboxylated osteocalcin) tend to have **weaker bones and higher fracture risk** in several research groups.
* These trials suggest that **you don’t necessarily need very high MK‑4 doses** to improve this marker; smaller daily amounts may also be enough for some people.
**Fraud issues in older high-dose MK-4 fracture literature**
Some older high-dose fracture literature was later undermined by fraudulent data.
Several older fracture claims trace back to retracted or unreliable datasets.
However, much of the data are still valid and defensible.
#### What remains from validated MK-4 work?
Not every positive MK-4 study was invalid.
Some validated studies still support the 15 mg three-times-daily approach.
A more recent study suggests lower daily dosing may also be enough for osteocalcin effects.
***
#### **MK-4 has a short half-life, often described as 2–3 hours.**
**That is why some clinicians prefer divided dosing.**
The lower-dose studies above still used once-daily dosing.
That means divided dosing remains a nuance, not settled dogma.
***
#### MK-7 and bone density - *mixed findings*
Improved osteocalcin carboxylation does not always translate into better bone-density outcomes.
In one osteopenia trial, 375 mcg MK-7 daily improved osteocalcin carboxylation.
It did not improve bone-turnover markers, bone mineral density, or bone microarchitecture over 3 years.
In the RenaKvit dialysis trial, MK-7 was linked to faster BMD loss at the distal radius over 2 years.
The same trial also suggested prevention of lumbar spine BMD decline.
Those findings are site-specific and population-specific.
They do not automatically translate into fracture outcomes.
***
#### MK-7 and vascular stiffness ("calcification")
There is also vascular-stiffness research in postmenopausal women.
That is part of the wider arterial-calcification discussion around K vitamins.
One conference abstract reported MK-7 reduced arterial stiffness in **postmenopausal women**.
Women with higher baseline arterial stiffness appeared to benefit most based on blood-pressure measures.
Further work is still needed to clarify the mechanism and clinical significance.
In **older men** with substantial aortic-valve calcification, 720 mcg MK-7 plus 25 mcg vitamin D for 2 years did not change AVC progression.
That was a specific male population so should not be treated as a direct proxy for postmenopausal women.
***
### K1 and MK‑4 for arterial calcification
Vitamin K1 (the main food form of vitamin K) can be converted into vitamin K2 MK‑4 inside the body.\
\
Because of this, researchers are interested in whether **low vitamin K intake or drug‑induced vitamin K depletion** might make it easier for calcium to build up in blood vessels (vascular calcification).
So far, human studies using MK‑4 to **reverse** existing arterial calcification are very limited, and we don’t yet have strong proof that MK‑4 can undo calcium deposits in human arteries.
One important animal study looked at rats given warfarin, a blood thinner that blocks vitamin K and can promote artery calcification.\
\
In that rat model, **very high doses of vitamin K1 or MK‑4 were able to reverse warfarin-induced arterial calcification.**
Animal studies suggest high-dose vitamin K can reverse warfarin-related arterial calcification. Human evidence remains limited.
### References
1. [Maximal dose-response of vitamin K2 (menaquinone-4) on undercarboxylated osteocalcin](https://pubmed.ncbi.nlm.nih.gov/30816822/)
2. [Effect of low dose vitamin K2 supplementation in postmenopausal Japanese women](https://pubmed.ncbi.nlm.nih.gov/19352059/)
3. [Osteocalcin and fracture risk context](https://www.jci.org/articles/view/116387)
4. [Undercarboxylated osteocalcin review context](https://pubmed.ncbi.nlm.nih.gov/35898467/)
5. [Researcher at the center of an epic fraud remains an enigma to those who exposed him](https://www.science.org/content/article/researcher-center-epic-fraud-remains-enigma-those-who-exposed-him)
6. [Meta-analysis caution on vitamin K and fracture prevention](https://pmc.ncbi.nlm.nih.gov/articles/PMC11845094/)
7. [Effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia](https://pubmed.ncbi.nlm.nih.gov/33030563/)
8. [RenaKvit trial](https://academic.oup.com/ndt/article/38/10/2131/6865373)
9. [Related editorial context on RenaKvit](https://academic.oup.com/ndt/article/38/10/2105/7190649?login=false)
10. [Beneficial effects of one-year menaquinone-7 supplementation on vascular stiffness and blood pressure in postmenopausal women](https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.2621/7391763)
11. [Vitamin K2 and D in patients with aortic valve calcification](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057008)
12. [Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats](https://pubmed.ncbi.nlm.nih.gov/17138823/)
### What’s in this hub
* [Bone density testing](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/bone-density-testing.md): DXA interpretation, T-scores, trabecular bone score, and scan-reading pitfalls.
* [Lab tests and root-cause workup](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/lab-tests-and-root-cause-workup.md): Baseline bloodwork, bone-turnover markers, and specialist follow-up tests.
* [Diet and protein](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/diet-and-protein.md): Protein targets, mineral priorities, and oxalate-related food notes.
* [Supplementation](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/supplementation.md): Calcium, vitamin D, magnesium, K vitamins, creatine, and related support notes.
* [Exercise and bone loading](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/exercise-and-bone-loading.md): Resistance work, impact loading, and bone-metastasis safety cautions.
* [Vitamin K2 research notes](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/vitamin-k2-research-notes.md): Reference links and caution notes on MK-4, MK-7, and arterial-calcification context.
* [Genistein and bone health](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/genistein-and-bone-health.md): Research notes on genistein for bone support, including oncology cautions.
---
# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.
## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/vitamin-k2-research-notes.md?ask=&goal=
```
`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.